Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
Home > Patient Care > Clinical Trials: Open Enrollment   
Clinical Trials: Open Enrollment
The following is a listing of all trials currently enrolling brain tumor patients at UCLA.
 
What clinical trials are available at UCLA Neuro-Oncology?
Choosing to participate in a clinical trial is an important, personal decision. It is often helpful to talk to a physician, family members, or friends about deciding to join a trial. After identifying some trial options, the next step is to contact the study research staff and ask questions about specific trials.

For more information about any of the UCLA Neuro-Oncology Program’s clinical trials listed, please contact Emese Filka, Clinical Trials Coordinator, at (310) 794-3521

Study AgentIRB IDTrial:Details
FMISO for Imaging12-000552[ACRIN 6684]:
5-FC (Flucytosine)10-001147[Tg 511-09-01]:
AMG59511-003531[(AMG 595) 20090505]:
Avastin (Bevacizumab) Genetech10-000760 (09-06-032)[AVF4535s Nghiemphu]:
BKM12011-001673[DFCI BKM120]:
CC-11512-000820[CC-115-ST-001]:
CDX-110, Temozolomide11-002220[Celldex CDX110-05] :
GDC-008411-003527[GO28070 GDC-0084]:
Lapatinib (GW572016), TMZ, RT12-000493[Lapatinib_Nghiemphu]:
Toca 51110-000484 (09-07-003)[Tg 511-08-01]:
Toca 511, 5-FC11-003256[Tg 511-11-01]:
VELCADE, TMZ, RT11-002222 (09-03-084)[Velcade X05303]:



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2013 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2013 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/20/2013 6:55:57 AM PST]